A. Van-deun, A. Maug, M. Salim, P. Das, M. Sarker et al., Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis, American Journal of Respiratory and Critical Care Medicine, vol.182, issue.5, pp.684-692, 2010.
DOI : 10.1164/rccm.201001-0077OC

C. Dye and B. Williams, Criteria for the control of drug-resistant tuberculosis, Proceedings of the National Academy of Sciences, vol.48, issue.30, pp.8180-8185, 2000.
DOI : 10.1073/pnas.95.7.3949

A. Bechtel-cremers, S. Janssen, M. Huson, G. Bikene, S. Belard et al., 2013. Perceptions, health care seeking behaviour and implementation of a tuberculosis control programme in Lambarene, Gabon. Public Health Action, vol.8, issue.3, pp.328-332, 2012.

S. Belard, J. Remppis, S. Bootsma, S. Janssen, D. Kombila et al., A Prospective Cohort Study, Tuberculosis Treatment Outcome and Drug Resistance in Lambarene Am J Trop Med Hyg, vol.doi, pp.10-426915, 2016.

D. Mounguengui, M. Ondounda, J. Lawson, M. Fabre, L. Gaudong et al., Tuberculose multirésistante à l'hôpital d'instruction des armées de Libreville (Gabon) à propos de 16 cas (Multi-resistant tuberculosis at the hôpital d'instruction des armées de Libreville (Gabon) about 16 cases), Bull Soc Pathol Exot, vol.105, p.4, 2012.
DOI : 10.1007/s13149-011-0195-8

S. Stolp, M. Huson, S. Janssen, J. Beyeme, M. Grobusch et al., Tuberculosis patients hospitalized in the Albert Schweitzer Hospital, Lambar en e, Gabon?a retrospective observational study WHO-recommandations. 2013 Tuberculosis diagnostics Xpert MTB Rapid Molecular Detection of Tuberculosis and Rifampin Resistance, Clinical Microbiology and Infection New England Journal of Medicine, vol.19, issue.363, pp.1005-1015, 2010.

S. Ramirez-busby and F. Valafar, Systematic Review of Mutations in Pyrazinamidase Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis Clinical Isolates, Antimicrobial Agents and Chemotherapy, vol.59, issue.9, pp.5267-5277, 2015.
DOI : 10.1128/AAC.00204-15

A. Sandgren, M. Strong, P. Muthukrishnan, B. Weiner, G. Church et al., Tuberculosis Drug Resistance Mutation Database, PLoS Medicine, vol.40, issue.2, p.2, 2009.
DOI : 10.1371/journal.pmed.1000002.sd001
URL : https://doi.org/10.1371/journal.pmed.1000002

A. Alame-emane, P. Xu, C. Pierre-audigier, V. Cadet-daniel, X. Shen et al., Pyrazinamide resistance in <I>Mycobacterium tuberculosis</I> arises after rifampicin and fluoroquinolone resistance, The International Journal of Tuberculosis and Lung Disease, vol.19, issue.6, pp.679-684, 2015.
DOI : 10.5588/ijtld.14.0768

D. Helb, M. Jones, E. Story, C. Boehme, E. Wallace et al., and Rifampin Resistance by Use of On-Demand, Near-Patient Technology, Journal of Clinical Microbiology, vol.48, issue.1, pp.229-237, 2010.
DOI : 10.1128/JCM.01463-09

V. Crudu, E. Stratan, E. Romancenco, V. Allerheiligen, A. Hillemann et al., First Evaluation of an Improved Assay for Molecular Genetic Detection of Tuberculosis as Well as Rifampin and Isoniazid Resistances, Journal of Clinical Microbiology, vol.50, issue.4, pp.1264-1269, 2012.
DOI : 10.1128/JCM.05903-11

C. Sola, E. Abadia, L. Hello, S. Weill, and F. , High-Throughput CRISPR Typing of Mycobacterium tuberculosis Complex and Salmonella enterica Serotype Typhimurium, Methods Mol Biol, vol.1311, pp.91-109, 2015.
DOI : 10.1007/978-1-4939-2687-9_6
URL : https://hal.archives-ouvertes.fr/pasteur-01159705

J. Kamerbeek, L. Schouls, A. Kolk, M. Van-agterveld, D. Van-soolingen et al., Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J Clin Microbiol, vol.35, pp.907-914, 1997.

I. Herrero, I. Mokrousov, S. Niemann, I. Kontsevaya, N. Rastogi et al., Proposal of a consensus set of hypervariable mycobacterial interspersed repetitive-unit-variable-number tandem-repeat loci for subtyping of Mycobacterium tuberculosis Beijing isolates, J Clin Microbiol, vol.52, pp.164-172, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01011025

T. Luo, C. Yang, S. Gagneux, B. Gicquel, J. Mei et al., Combination of Single Nucleotide Polymorphism and Variable-Number Tandem Repeats for Genotyping a Homogenous Population of Mycobacterium tuberculosis Beijing Strains in China, Journal of Clinical Microbiology, vol.50, issue.3, pp.633-639, 2012.
DOI : 10.1128/JCM.05539-11

A. Pym, B. Saint-joanis, and S. Cole, Effect of katG Mutations on the Virulence of Mycobacterium tuberculosis and the Implication for Transmission in Humans, Infection and Immunity, vol.70, issue.9, pp.4955-4960, 2002.
DOI : 10.1128/IAI.70.9.4955-4960.2002

M. Hazbon, M. Brimacombe, B. Del-valle, M. Cavatore, M. Guerrero et al., Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.50, issue.8, pp.2640-2649, 2006.
DOI : 10.1128/AAC.00112-06

S. Chakravorty, B. Aladegbami, A. Motiwala, Y. Dai, H. Safi et al., Rifampin resistance, Beijing-W clade-single nucleotide polymorphism cluster 35 Tuberculosis -A global emergency: Tools and methods to monitor, understand, and control the epidemic with specific example of the Beijing lineage, Tuberculosis (Edinb), vol.95, issue.1, pp.177-189, 2008.

T. Ouassa, E. Borroni, G. Loukou, H. Faye-kette, J. Kouakou et al., High Prevalence of Shared International Type 53 among Mycobacterium tuberculosis Complex Strains in Retreated Patients from C??te d???Ivoire, PLoS ONE, vol.7, issue.9, p.45363, 2012.
DOI : 10.1371/journal.pone.0045363.t003

F. Coll, R. Mcnerney, M. Preston, J. Guerra-assuncao, A. Warry et al., Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences, Genome Medicine, vol.7, issue.1, p.51, 2015.
DOI : 10.1371/journal.pone.0041253
URL : https://genomemedicine.biomedcentral.com/track/pdf/10.1186/s13073-015-0164-0?site=genomemedicine.biomedcentral.com

P. Bradley, N. Gordon, T. Walker, L. Dunn, S. Heys et al., Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples, J Clin Microbiol, vol.53, pp.2230-2237, 2015.

E. Karlsson, A. Larkeryd, A. Sjodin, M. Forsman, and P. Stenberg, Scaffolding of a bacterial genome using MinION nanopore sequencing, Scientific Reports, vol.11, issue.1, p.11996, 2015.
DOI : 10.1186/1471-2105-11-80

R. Koch, The Etiology of Tuberculosis, Clinical Infectious Diseases, vol.4, issue.6, p.7, 1882.
DOI : 10.1093/clinids/4.6.1270

A. Van-deun, A. Maug, and M. Salim, Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis, American Journal of Respiratory and Critical Care Medicine, vol.182, issue.5, pp.684-92, 2010.
DOI : 10.1164/rccm.201001-0077OC

A. Zumla, P. Nahid, and S. Cole, Advances in the development of new tuberculosis drugs and treatment regimens, Nature Reviews Drug Discovery, vol.109, issue.5, pp.388-404, 2013.
DOI : 10.1073/pnas.1205735109

M. Espinal and C. Dye, Can DOTS control multidrug-resistant tuberculosis?, The Lancet, vol.365, issue.9466, pp.1206-1215, 2005.
DOI : 10.1016/S0140-6736(05)74788-7

P. Farmer and J. Kim, Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus", BMJ, vol.317, issue.7159, pp.671-675, 1998.
DOI : 10.1136/bmj.317.7159.671

A. Van-rie and D. Enarson, XDR tuberculosis: an indicator of public-health negligence, The Lancet, vol.368, issue.9547
DOI : 10.1016/S0140-6736(06)69575-5

K. Floyd, R. Hutubessy, and K. Kliiman, Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia, European Respiratory Journal, vol.40, issue.1, pp.133-175, 2012.
DOI : 10.1183/09031936.00169411

P. Andersen and T. Doherty, Opinion: The success and failure of BCG ??? implications for a novel tuberculosis vaccine, Nature Reviews Microbiology, vol.171, issue.8, pp.656-62, 2005.
DOI : 10.4049/jimmunol.171.3.1602

K. Aung, A. Van-deun, and E. Declercq, Successful ???9-month Bangladesh regimen??? for multidrug-resistant tuberculosis among over 500 consecutive patients, The International Journal of Tuberculosis and Lung Disease, vol.18, issue.10, pp.1180-1187, 2014.
DOI : 10.5588/ijtld.14.0100

T. Doherty and P. Andersen, Vaccines for Tuberculosis: Novel Concepts and Recent Progress, Clinical Microbiology Reviews, vol.18, issue.4, pp.687-702, 2005.
DOI : 10.1128/CMR.18.4.687-702.2005
URL : http://cmr.asm.org/content/18/4/687.full.pdf

J. Caminero, G. Sotgiu, and A. Zumla, Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis, The Lancet Infectious Diseases, vol.10, issue.9, pp.621-630, 2010.
DOI : 10.1016/S1473-3099(10)70139-0

P. Glaziou, C. Sismanidis, and K. Floyd, Global Epidemiology of Tuberculosis, Cold Spring Harbor Perspectives in Medicine, vol.5, issue.2, p.17798, 2014.
DOI : 10.1101/cshperspect.a017798

C. Lienhardt, P. Glaziou, and M. Uplekar, Global tuberculosis control: lessons learnt and future prospects, Nature Reviews Microbiology, vol.89, pp.407-423, 2012.
DOI : 10.2471/BLT.11.086801

B. Amor, Y. Nemser, B. Singh, and A. , Underreported Threat of Multidrug-Resistant Tuberculosis in Africa, Emerging Infectious Diseases, vol.14, issue.9, pp.1345-52, 2003.
DOI : 10.3201/eid1409.061524

T. Bodmer and A. Strohle, Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test, Journal of Visualized Experiments, issue.62
DOI : 10.3791/3547
URL : https://www.jove.com/pdf/3547/diagnosing-pulmonary-tuberculosis-with-the-xpert-mtbrif-test

P. Nabeta and D. Hillemann, Rapid Molecular Detection of Tuberculosis and Rifampin Resistance, J Vis Exp New England Journal of Medicine, vol.2012, issue.363, pp.1005-1020, 2010.

C. Boehme, M. Nicol, and P. Nabeta, Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study, The Lancet, vol.377, issue.9776, pp.1495-505, 2011.
DOI : 10.1016/S0140-6736(11)60438-8

V. Crudu, E. Stratan, and E. Romancenco, First Evaluation of an Improved Assay for Molecular Genetic Detection of Tuberculosis as Well as Rifampin and Isoniazid Resistances, Journal of Clinical Microbiology, vol.50, issue.4, pp.1264-1273, 2012.
DOI : 10.1128/JCM.05903-11

Z. Dezemon, C. Muvunyi, and O. Jacob4, Staining techniques for detection of acid fast bacilli: what hope does fluorescein-diacetate (FDA) vitality staining technique represent for the monitoring of tuberculosis treatment in resource limited settings, Herbert Open Access Journals, vol.10, 2000.

I. Rashid, L. Mabuza, and I. Govender, Volume of sputum to detect acid-fast bacilli as a measure of quality for the diagnosis of pulmonary tuberculosis at the Dr George Mukhari Hospital, South Africa, African Journal of Primary Health Care & Family Medicine, vol.3, issue.1, p.6, 2011.
DOI : 10.1128/JCM.40.2.508-511.2002

Y. Shea, J. Davis, and L. Huang, High Sensitivity and Specificity of Acid-Fast Microscopy for Diagnosis of Pulmonary Tuberculosis in an African Population with a High Prevalence of Human Immunodeficiency Virus, Journal of Clinical Microbiology, vol.47, issue.5, pp.1553-1558, 2009.
DOI : 10.1128/JCM.00348-09

K. Steingart, A. Ramsay, and M. Pai, Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis, Expert Review of Anti-infective Therapy, vol.7, issue.3, pp.327-358, 2007.
DOI : 10.1016/S1473-3099(07)70060-9

M. Marin, D. Garcia-de-viedma, and M. Ruiz-serrano, Rapid Direct Detection of Multiple Rifampin and Isoniazid Resistance Mutations in Mycobacterium tuberculosis in Respiratory Samples by Real-Time PCR, Antimicrobial Agents and Chemotherapy, vol.48, issue.11, pp.4293-300, 2004.
DOI : 10.1128/AAC.48.11.4293-4300.2004

J. Blanchard, Molecular Mechanisms of Drug Resistance in Mycobacterium Tuberculosis, Annual Review of Biochemistry, vol.65, issue.1, p.25, 1996.
DOI : 10.1146/annurev.bi.65.070196.001243

R. Ghodbane, D. Raoult, and M. Drancourt, Dramatic reduction of culture time of Mycobacterium tuberculosis, Scientific Reports, vol.46, issue.1, p.4236, 2014.
DOI : 10.1128/JCM.02183-07

Y. Zhang, W. Shi, and W. Zhang, Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations, Mechanisms of Pyrazinamide Action and Resistance. Microbiology spectrum Antimicrobial agents and chemotherapy, vol.2, issue.38, pp.773-80, 1994.

A. Telenti, P. Imboden, and F. Marchesi, Detection of rifampicin-resistance mutations in 33 Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis, Molecular microbiology, vol.15, pp.235-280, 1995.

B. Heym, Y. Zhang, and S. Poulet, Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis., Journal of Bacteriology, vol.175, issue.13, pp.4255-4264, 1993.
DOI : 10.1128/jb.175.13.4255-4259.1993

C. Surcouf, S. Heng, and C. Pierre-audigier, Molecular detection of fluoroquinoloneresistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis Bidovec-Stojkovic U, Seme K, Zolnir-Dovc M et al. Prospective genotyping of Mycobacterium tuberculosis from fresh clinical samples, et al. A Rapid and Sensitive Diagnostic Screening Assay for Detection of Mycobacteria Including Mycobacterium tuberculosis Directly from Sputum without Extraction, pp.255-291, 2003.

P. Cafrune, L. Possuelo, and A. Ribeiro, Prospective study applying spoligotyping directly to DNA from sputum samples of patients suspected of having tuberculosis Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background, Can J Microbiol The Journal of infection, vol.55, issue.62, pp.212-219, 2009.

M. Ruiz, M. Torres, and A. Llanos, Direct Detection of Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis in Auramine-Rhodamine-Positive Sputum Specimens by Real-Time PCR, Journal of Clinical Microbiology, vol.42, issue.4, pp.1585-1594, 2004.
DOI : 10.1128/JCM.42.4.1585-1589.2004

F. Brossier, N. Veziris, and C. Truffot-pernot, Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level Resistance, Journal of Clinical Microbiology, vol.44, issue.10, pp.3659-64, 2006.
DOI : 10.1128/JCM.01054-06

D. Hillemann, S. Rusch-gerdes, and E. Richter, Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens, Journal of Clinical Microbiology, vol.45, issue.8, pp.2635-2675, 2007.
DOI : 10.1128/JCM.00521-07

E. Richter, M. Weizenegger, and S. Rusch-gerdes, Evaluation of Genotype MTBC Assay for Differentiation of Clinical Mycobacterium tuberculosis Complex Isolates, Journal of Clinical Microbiology, vol.41, issue.6, pp.2672-2677, 2003.
DOI : 10.1128/JCM.41.6.2672-2675.2003

. Bechtel, Schéma Directeur National d'Infrastructure, Republique du Gabon, vol.101, 2012.

S. Belard, J. Remppis, and S. Bootsma, Tuberculosis Treatment Outcome and Drug Resistance in Lambar??n??, Gabon: A Prospective Cohort Study, The American Journal of Tropical Medicine and Hygiene, vol.95, issue.2, pp.472-80, 2016.
DOI : 10.4269/ajtmh.15-0668

D. Nkoghe, M. Mve, and S. Nnegue, Séroprévalence du VIH au sein des tuberculeux de l'hôpital de Nkembo à Libreville, Gabon. Bulletin de la Societe de pathologie exotique Clinical and laboratory features of tuberculosis within a hospital population in Libreville, Gabon, Infection, vol.98, issue.41, pp.737-746, 1990.

S. Stolp, M. Huson, and S. Janssen, Tuberculosis patients hospitalized in the Albert Schweitzer Hospital, Lambarene, Gabon?a retrospective observational study Perceptions, health care seeking behaviour and implementation of a tuberculosis control programme in Lambarene, search of a new paradigm for protective immunity to TB, pp.3-51, 2013.

J. Pieters, Mycobacterium tuberculosis and the Macrophage: Maintaining a Balance, Cell Host & Microbe, vol.3, issue.6
DOI : 10.1016/j.chom.2008.05.006
URL : https://doi.org/10.1016/j.chom.2008.05.006

P. Glaziou, C. Sismanidis, and K. Floyd, Global Epidemiology of Tuberculosis, a017798. 55. Economiques DGdlSedE. Annuaire statistique du Gabon. In: Générales DdS, 2015.
DOI : 10.1101/cshperspect.a017798

D. Mounguengui, M. Ondounda, and J. Lawson, Tuberculose multirésistante à l'hôpital d'instruction des armées de Libreville (Gabon) à propos de 16 cas (Multi-resistant tuberculosis at the hôpital d'instruction des
DOI : 10.1007/s13149-011-0195-8

M. Huson, R. Kalkman, and S. Stolp, The impact of HIV on presentation and outcome of bacterial sepsis and other causes of acute febrile illness in Gabon, Infection, vol.15, issue.4, pp.4-58, 1990.
DOI : 10.3201/eid1504.080664

A. Aranaz, D. Cousins, and A. Mateos, Elevation of Mycobacterium tuberculosis subsp

. Aranaz, Elevation of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to species rank as Mycobacterium caprae comb. nov., sp. nov., INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, vol.53, issue.6, pp.1785-1794, 1999.
DOI : 10.1099/ijs.0.02532-0

M. Coscolla, A. Lewin, and S. Metzger, Novel Mycobacterium tuberculosis Complex Isolate from a Wild Chimpanzee Emerging infectious diseases 2013 Distinct genotypic profiles of the two major clades of Mycobacterium africanum Association between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistance, Infectious Diseases PloS one, vol.19, issue.8, pp.8-62, 2010.

K. Alexander, E. Pleydell, and M. Williams, : An Emerging Disease of Free-Ranging Wildlife, Emerging Infectious Diseases, vol.8, issue.6, pp.598-601, 2002.
DOI : 10.3201/eid0806.010358

C. Collins, M. Yates, and J. Grange, SUMMARY, Journal of Hygiene, vol.108, issue.02, pp.235-277, 1982.
DOI : 10.1099/00207713-28-4-464
URL : https://hal.archives-ouvertes.fr/hal-01407396

G. Garrity, D. Brenner, and N. Krieg, Bergey's Manual of Systematic Bacteriology: The

P. Garrity, G. Brenner, D. Krieg, and N. , How sisters grow apart: mycobacterial growth and division, Nature reviews Microbiology, vol.12, pp.550-62, 2005.

M. Jankute, J. Cox, and J. Harrison, Assembly of the Mycobacterial Cell Wall, Marmiesse M et al. A new evolutionary scenario for the, pp.405-428, 2015.
DOI : 10.1146/annurev-micro-091014-104121

M. Sales, A. Fonseca, J. Sales, and E. , Mycobacterium tuberculosis complex Evaluation of molecular markers for the diagnosis of Mycobacterium bovis, Proceedings of the National Academy of Sciences of the United States of America Folia microbiologica, vol.99, issue.59, pp.3684-3693, 2002.

M. Tsukamura, Numerical Classification of 280 Strains of Slowly Growing Mycobacteria, Microbiology and Immunology, vol.23, issue.3
DOI : 10.1099/00207713-23-2-182

D. Labie, Le g??nome des mycobact??ries : ??tude biologique et interpr??tation ??volutive, m??decine/sciences, vol.19, issue.3
DOI : 10.1051/medsci/2003193275

S. Borrell and S. Gagneux, Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis. Clinical microbiology and infection : the official publication of the European Society of, Clinical Microbiology and Infectious Diseases, vol.17, pp.815-835, 2011.

K. Brudey, J. Driscoll, and L. Rigouts, Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies Sublineage structure analysis of Mycobacterium tuberculosis complex strains using multiple-biomarker tensors, BMC microbiology PloS one BMC genomics, vol.6, issue.12 2, p.1, 2006.

D. Stucki, B. Malla, and S. Hostettler, Two new rapid SNP-typing methods for classifying Mycobacterium tuberculosis complex into the main phylogenetic lineages Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome, PloS one Molecular microbiology, vol.7, issue.36, pp.762-71, 2000.

S. Cole, R. Brosch, and J. Parkhill, Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature, vol.25, issue.6685, pp.537-581, 1998.
DOI : 10.1093/nar/25.5.0955

P. Groenen, A. Bunschoten, and D. Van-soolingen, Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method, Molecular Microbiology, vol.85, issue.5, pp.1057-65, 1993.
DOI : 10.1016/0923-2508(92)90104-V

J. Zhang, E. Abadia, and G. Refregier, Mycobacterium tuberculosis complex CRISPR genotyping: improving efficiency, throughput and discriminative power of 'spoligotyping' with new spacers and a microbead-based hybridization assay, Journal of Medical Microbiology, vol.59, issue.3, pp.285-94, 2010.
DOI : 10.1099/jmm.0.016949-0
URL : https://hal.archives-ouvertes.fr/hal-00527223

J. Cohen, DNA fingerprinting for forensic identification: potential effects on data interpretation of subpopulation heterogeneity and band number variability, American journal of human genetics, vol.46, pp.358-68, 1990.

P. Gill, A. Jeffreys, and D. Werrett, Forensic application of DNA ???fingerprints???, Nature, vol.13, issue.6046, pp.577-586, 1985.
DOI : 10.1520/JFS10562J

A. Hill and A. Jeffreys, USE OF MINISATELLITE DNA PROBES FOR DETERMINATION OF TWIN ZYGOSITY AT BIRTH, The Lancet, vol.326, issue.8469-8470, pp.1394-1399, 1985.
DOI : 10.1016/S0140-6736(85)92558-9

R. Frothingham, W. Meeker-o-'connell, M. J. Himpens, and S. , Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats Identification of novel intergenic repetitive units in a mycobacterial two-component system operon Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis, Microbiology (Reading, England) Molecular microbiology J Clin Microbiol, vol.144, issue.44, pp.1189-96, 1997.

S. Gordon, R. Brosch, and A. Billault, Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays, Molecular Microbiology, vol.22, issue.3, pp.643-55, 1999.
DOI : 10.1099/00221287-138-4-825

M. Behr, M. Wilson, and W. Gill, Comparative genomics of BCG vaccines by wholegenome DNA microarray Mycobacterium africanum--review of an important cause of human tuberculosis in West Africa Mycobacterial lineages causing pulmonary and extrapulmonary tuberculosis Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements, Science PLoS neglected tropical diseases Ethiopia. Emerging infectious diseases Journal of internal medicine, vol.284, issue.249, pp.1520-1523, 1999.

K. Vanden-driessche, A. Persson, and B. Marais, Immune Vulnerability of Infants to Tuberculosis, Clinical and Developmental Immunology, vol.175, issue.5, p.781320, 2013.
DOI : 10.1016/j.cell.2004.11.038

B. Saunders and W. Britton, Life and death in the granuloma: immunopathology of tuberculosis, Immunology and Cell Biology, vol.173, issue.2, pp.103-114, 2007.
DOI : 10.4049/jimmunol.173.5.3287

N. Martinson, C. Hoffmann, and R. Chaisson, Epidemiology of Tuberculosis and HIV: Recent Advances in Understanding and Responses, Proceedings of the American Thoracic Society, vol.8, issue.3, pp.288-93, 2011.
DOI : 10.1513/pats.201010-064WR

M. Raviglione and G. Sulis, Tuberculosis 2015: burden, challenges and strategy for control and elimination, Infectious Disease Reports, vol.8, issue.2, p.6570, 2016.
DOI : 10.4081/idr.2016.6570
URL : http://www.pagepress.org/journals/index.php/idr/article/download/6570/5995

J. Casanova and L. Abel, The human model: a genetic dissection of immunity to infection in natural conditions, Nature Reviews Immunology, vol.4, issue.1, pp.55-66, 2004.
DOI : 10.1038/nri1264

R. Blomgran, L. Desvignes, and V. Briken, Mycobacterium tuberculosis Inhibits Neutrophil Apoptosis, Leading to Delayed Activation of Naive CD4 T??cells, Cell Host & Microbe, vol.11, issue.1, pp.81-90, 2012.
DOI : 10.1016/j.chom.2011.11.012
URL : https://doi.org/10.1016/j.chom.2011.11.012

J. Davis and L. Ramakrishnan, The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection, Cell, vol.136, issue.1, pp.37-49, 2009.
DOI : 10.1016/j.cell.2008.11.014

C. Martin, M. Booty, and T. Rosebrock, Efferocytosis Is an Innate Antibacterial Mechanism, Cell Host & Microbe, vol.12, issue.3, pp.289-300, 2012.
DOI : 10.1016/j.chom.2012.06.010
URL : https://doi.org/10.1016/j.chom.2012.06.010

A. Wolf, B. Linas, and G. Trevejo-nunez, Mycobacterium tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In Vivo, The Journal of Immunology, vol.179, issue.4, pp.2509-2528, 1950.
DOI : 10.4049/jimmunol.179.4.2509
URL : http://www.jimmunol.org/content/jimmunol/179/4/2509.full.pdf

W. Hanekom, M. Mendillo, and C. Manca, Inhibits Maturation of Human Monocyte???Derived Dendritic Cells In Vitro, The Journal of Infectious Diseases, vol.188, issue.2, pp.257-66, 2003.
DOI : 10.1086/376451

Q. Zhang and I. Sugawara, Immunology of tuberculosis, World Journal of Experimental Medicine, vol.2, issue.4, pp.70-74, 2012.
DOI : 10.5493/wjem.v2.i4.70

D. Russell, Mycobacterium tuberculosis: here today, and here tomorrow, Nature Reviews Molecular Cell Biology, vol.59, issue.8, pp.569-77, 2001.
DOI : 10.1016/S0006-2952(99)00253-1

J. Armstrong and P. Hart, Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival, Journal of Experimental Medicine, vol.142, issue.1, pp.1-16, 1975.
DOI : 10.1084/jem.142.1.1
URL : http://jem.rupress.org/content/jem/142/1/1.full.pdf

I. Orme, A new unifying theory of the pathogenesis of tuberculosis, Tuberculosis, vol.94, issue.1, pp.8-14, 2014.
DOI : 10.1016/j.tube.2013.07.004

L. Ramakrishnan, Revisiting the role of the granuloma in tuberculosis, Nature Reviews Immunology, vol.288, pp.352-66, 2012.
DOI : 10.1126/science.288.5470.1436

L. Tailleux, O. Neyrolles, and S. Honore-bouakline, Constrained Intracellular Survival of Mycobacterium tuberculosis in Human Dendritic Cells, The Journal of Immunology, vol.170, issue.4, pp.1939-1987, 1950.
DOI : 10.4049/jimmunol.170.4.1939

X. Jiao, R. Lo-man, and P. Guermonprez, Dendritic Cells Are Host Cells for Mycobacteria In Vivo That Trigger Innate and Acquired Immunity, The Journal of Immunology, vol.168, issue.3, pp.1294-301, 1950.
DOI : 10.4049/jimmunol.168.3.1294
URL : http://www.jimmunol.org/content/jimmunol/168/3/1294.full.pdf

H. Volkman, H. Clay, and D. Beery, Tuberculous Granuloma Formation Is Enhanced by a Mycobacterium Virulence Determinant, PLoS Biology, vol.79, issue.11, p.367, 2004.
DOI : 10.1371/journal.pbio.0020367.g010
URL : https://doi.org/10.1371/journal.pbio.0020367

C. Yang, C. Cambier, and J. Davis, Neutrophils Exert Protection in the Early Tuberculous Granuloma by Oxidative Killing of Mycobacteria Phagocytosed from Infected Macrophages, Cell Host & Microbe, vol.12, issue.3, pp.301-313, 2012.
DOI : 10.1016/j.chom.2012.07.009

J. Flynn, J. Chan, and P. Lin, Macrophages and control of granulomatous inflammation in tuberculosis, Mucosal Immunology, vol.180, issue.3, pp.271-279, 2011.
DOI : 10.4049/jimmunol.180.5.3329

L. Swaim, L. Connolly, and H. Volkman, Mycobacterium marinum Infection of Adult Zebrafish Causes Caseating Granulomatous Tuberculosis and Is Moderated by Adaptive Immunity, Infection and Immunity, vol.74, issue.11, pp.6108-6125, 2006.
DOI : 10.1128/IAI.00887-06
URL : http://iai.asm.org/content/74/11/6108.full.pdf

T. Hsu, S. Hingley-wilson, and C. B. , The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue, Proceedings of the National Academy of Sciences, vol.393, issue.6685, pp.12420-12425, 2003.
DOI : 10.1038/31159

A. Geluk, K. Van-meijgaarden, and K. Franken, Identification of Major Epitopes of Mycobacterium tuberculosis AG85B That Are Recognized by HLA-A*0201-Restricted CD8+ T Cells in HLA-Transgenic Mice and Humans, The Journal of Immunology, vol.165, issue.11, pp.6463-71, 1950.
DOI : 10.4049/jimmunol.165.11.6463

L. Grode, P. Seiler, and S. Baumann, Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin, Journal of Clinical Investigation, vol.115, issue.9
DOI : 10.1172/JCI24617
URL : http://www.jci.org/articles/view/24617/files/pdf

A. Somoskovi, L. Parsons, and M. Salfinger, The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis, Respiratory Research, vol.2, issue.3, pp.164-172, 2001.
DOI : 10.1186/rr54

D. Mitchison, The Diagnosis and Therapy of Tuberculosis During the Past 100 Years, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.7
DOI : 10.1164/rccm.200411-1603OE

A. Kanabus, Information about tuberculosis

W. Organization, Guidelines for the programmatic management of drug-resistant tuberculosis, 2014.

C. Kuaban, J. Noeske, and H. Rieder, High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon, The International Journal of Tuberculosis and Lung Disease, vol.19, issue.5, pp.517-541, 2015.
DOI : 10.5588/ijtld.14.0535

L. Guglielmetti, L. Du, D. Veziris, and N. , Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis? The European respiratory journal, 2016.

H. Hoffmann, T. Kohl, and S. Hofmann-thiel, Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee, American Journal of Respiratory and Critical Care Medicine, vol.193, issue.3, pp.337-377, 2016.
DOI : 10.1164/rccm.201502-0372LE

M. Lachatre, C. Rioux, L. Du, and D. , Bedaquiline plus delamanid for XDR tuberculosis, The Lancet Infectious Diseases, vol.16, issue.3
DOI : 10.1016/S1473-3099(16)00047-5

M. Tadolini, R. Lingtsang, and S. Tiberi, First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline. The European respiratory journal, 2016.
DOI : 10.1183/13993003.00637-2016
URL : http://erj.ersjournals.com/content/erj/48/3/935.full.pdf

Y. Zhang and W. Yew, Mécanismes de la résistance aux médicaments chez Mycobacterium tuberculosis, Int J Tuberc Lung Dis, vol.13, p.12, 2009.

T. Rodwell, F. Valafar, and J. Douglas, Predicting Extensively Drug-Resistant Mycobacterium tuberculosis Phenotypes with Genetic Mutations, Journal of Clinical Microbiology, vol.52, issue.3, pp.781-790, 2014.
DOI : 10.1128/JCM.02701-13
URL : http://jcm.asm.org/content/52/3/781.full.pdf

M. Mcgrath, G. Van-pittius, N. Van-helden, and P. , Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis, Journal of Antimicrobial Chemotherapy, vol.69, issue.2, pp.292-302, 2014.
DOI : 10.1093/jac/dkt364

D. Laurenzo and S. Mousa, Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing, Acta Tropica, vol.119, issue.1, pp.5-10, 2011.
DOI : 10.1016/j.actatropica.2011.04.008

D. Mitchison, How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis, Int J Tuberc Lung Dis, vol.2, pp.10-15, 1998.

S. Gagneux, Fitness cost of drug resistance in Mycobacterium tuberculosis Clinical microbiology and infection : the official publication of the European Society of, Clinical Microbiology and Infectious Diseases, vol.15, issue.1, pp.66-74, 2009.

F. Jamieson, J. Guthrie, and A. Neemuchwala, Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosis, Journal of Clinical Microbiology, vol.52, issue.6, pp.2157-62, 2014.
DOI : 10.1128/JCM.00691-14

M. Heep, B. Brandstatter, and U. Rieger, Frequency of rpoB Mutations Inside and Outside the Cluster I Region in Rifampin-Resistant Clinical Mycobacterium tuberculosis Isolates, Journal of Clinical Microbiology, vol.39, issue.1
DOI : 10.1128/JCM.39.1.107-110.2001

C. Pierre-audigier and B. Gicquel, The Contribution of Molecular Biology in Diagnosing Tuberculosis and Detecting Antibiotic Resistance, p.47, 2011.

W. Huang, T. Chi, and M. Wu, Test and DNA Sequencing for Detection of Second-Line and Ethambutol Drug Resistance among Patients Infected with Multidrug-Resistant Mycobacterium tuberculosis, Journal of Clinical Microbiology, vol.49, issue.7, pp.2502-2510, 2011.
DOI : 10.1128/JCM.00197-11

C. Mayer and H. Takiff, The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis, Microbiology Spectrum, vol.2, issue.4, pp.2-0009, 2014.
DOI : 10.1128/microbiolspec.MGM2-0009-2013

E. Avalos, D. Catanzaro, and A. Catanzaro, Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A Systematic Review, PLOS ONE, vol.55, issue.5, p.120470, 2015.
DOI : 10.1371/journal.pone.0120470.s003

J. Li, X. Gao, and T. Luo, Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis, Emerging Microbes & Infections, vol.36, issue.3, p.19, 2014.
DOI : 10.1086/605576

M. Willby, R. Sikes, and S. Malik, Correlation between GyrA Substitutions and Ofloxacin, Levofloxacin, and Moxifloxacin Cross-Resistance in Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.59, issue.9
DOI : 10.1128/AAC.00662-15
URL : http://aac.asm.org/content/59/9/5427.full.pdf

Y. Zhang, B. Heym, and A. B. , The catalase???peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis, Nature, vol.358, issue.6387, pp.591-594, 1992.
DOI : 10.1038/358591a0

C. Cade, A. Dlouhy, and K. Medzihradszky, Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities, Protein science : a publication of the Protein Society, vol.19, pp.458-74, 2010.
DOI : 10.1002/pro.324
URL : http://onlinelibrary.wiley.com/doi/10.1002/pro.324/pdf

S. Gagneux, M. Burgos, and K. Deriemer, Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis, PLoS Pathogens, vol.101, issue.6, p.61, 2006.
DOI : 0027-8424(2004)101[4865:FAEGOM]2.0.CO;2

B. Chia, F. Lanzas, and D. Rifat, Use of Multiplex Allele-Specific Polymerase Chain Reaction (MAS-PCR) to Detect Multidrug-Resistant Tuberculosis in Panama, PLoS ONE, vol.12, issue.7, p.40456, 2012.
DOI : 10.1371/journal.pone.0040456.t002

A. Telenti, W. Philipp, and S. Sreevatsan, The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol, Nature Medicine, vol.37, issue.5, pp.567-70, 1997.
DOI : 10.1128/AAC.37.10.2054

G. Alangaden, B. Kreiswirth, and A. Aouad, Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis, Antimicrobial agents and chemotherapy, vol.42, pp.1295-1302, 1998.

E. Tagliani, A. Cabibbe, and P. Miotto, Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study, Journal of Clinical Microbiology, vol.53, issue.9, pp.2961-2970, 2015.
DOI : 10.1128/JCM.01257-15

Y. Zhang and D. Mitchison, The curious characteristics of pyrazinamide: a review, Int J Tuberc Lung Dis, vol.7, pp.6-21, 2003.

E. Jaramillo, K. Weyer, and M. Raviglione, Linezolid for extensively drug-resistant tuberculosis, The New England journal of medicine, vol.368, p.290, 2013.

G. Bloemberg, P. Keller, and D. Stucki, Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis, New England Journal of Medicine, vol.373, issue.20, pp.1986-1994, 2015.
DOI : 10.1056/NEJMc1505196
URL : http://www.nejm.org/doi/pdf/10.1056/NEJMc1505196

M. Whitfield, H. Soeters, and R. Warren, A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis, PLOS ONE, vol.45, issue.1, p.133869, 2015.
DOI : 10.1371/journal.pone.0133869.s003
URL : http://doi.org/10.1371/journal.pone.0133869

R. Johnson, R. Warren, and O. Strauss, An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa, Int J Tuberc Lung Dis, vol.10, pp.1412-1416, 2006.

S. Gagneux, C. Long, and P. Small, The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis, Science, vol.312, issue.5782, pp.1944-1950, 2006.
DOI : 10.1126/science.1124410

L. Fenner, M. Egger, and T. Bodmer, Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.56, issue.6, pp.3047-53, 2012.
DOI : 10.1128/AAC.06460-11

T. Cohen, B. Sommers, and M. Murray, The effect of drug resistance on the fitness of Mycobacterium tuberculosis, The Lancet Infectious Diseases, vol.3, issue.1, pp.13-21, 2003.
DOI : 10.1016/S1473-3099(03)00483-3

W. Organization, Global tuberculosis report 2015, World Health Organization, vol.204, 2015.

R. Maclean and T. Vogwill, Limits to compensatory adaptation and the persistence of antibiotic resistance in pathogenic bacteria, Evolution, Medicine, and Public Health, vol.2015, issue.1, pp.4-12, 2014.
DOI : 10.1093/emph/eou032

M. De-vos, B. Muller, and S. Borrell, Putative Compensatory Mutations in the rpoC Gene of Rifampin-Resistant Mycobacterium tuberculosis Are Associated with Ongoing Transmission, Antimicrobial Agents and Chemotherapy, vol.57, issue.2
DOI : 10.1128/AAC.01541-12

V. Moing, Intérêts et limites des tests de détection de l'interféron ? dans le diagnostic de la tuberculose, La Lettre du Pneumologue, vol.15, p.4, 2012.

M. Pai, A. Zwerling, and D. Menzies, Systematic Review: T-Cell???based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update, Annals of Internal Medicine, vol.149, issue.3, pp.177-84, 2008.
DOI : 10.7326/0003-4819-149-3-200808050-00241

M. Perkins and J. Cunningham, Facing the Crisis: Improving the Diagnosis of Tuberculosis in the HIV Era, The Journal of Infectious Diseases, vol.196, issue.s1, pp.15-27, 2007.
DOI : 10.1086/518656

N. Nhu, D. Ha, and N. Anh, Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis, BMC Infectious Diseases, vol.6, issue.9, p.31, 2013.
DOI : 10.2217/fmb.11.84

M. Matee, L. Mtei, and T. Lounasvaara, Sputum microscopy for the diagnosis of HIV-associated pulmonary tuberculosis in Tanzania, BMC Public Health, vol.78, issue.1, p.68, 2008.
DOI : 10.1016/j.healthpol.2005.11.010

D. Van-soolingen, A. Van-der-zanden, and P. De-haas, Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers, J Clin Microbiol, vol.36, pp.1840-1845, 1998.

C. Loiez-durocher, A. Vachee, and N. Lemaitre, Drug resistance in Mycobacterium tuberculosis: diagnostic methods], Annales de biologie clinique, vol.58, pp.291-298, 2000.

D. Helb, M. Jones, and E. Story, and Rifampin Resistance by Use of On-Demand, Near-Patient Technology, Journal of Clinical Microbiology, vol.48, issue.1, pp.229-266, 2010.
DOI : 10.1128/JCM.01463-09

D. Bang, S. Andersen, and E. Vasiliauskiene, Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania, Diagnostic microbiology and infectious disease 2016
DOI : 10.1016/j.diagmicrobio.2016.08.026

S. Singh, A. Singh, and S. Prajapati, Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis, BMC Microbiology, vol.48, issue.11, p.191, 2015.
DOI : 10.1128/JCM.01463-09

N. Gous, L. Scott, and S. Khan, Diagnosing childhood pulmonary tuberculosis using a single sputum specimen on Xpert MTB/RIF at point of care. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, pp.1044-1052, 2015.

S. Matrat, N. Veziris, and C. Mayer, Functional Analysis of DNA Gyrase Mutant Enzymes Carrying Mutations at Position 88 in the A Subunit Found in Clinical Strains of Mycobacterium tuberculosis Resistant to Fluoroquinolones, Antimicrobial Agents and Chemotherapy, vol.50, issue.12, pp.4170-4173, 2006.
DOI : 10.1128/AAC.00944-06

T. Kocagoz, C. Hackbarth, and I. Unsal, Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra, Antimicrob Agents Chemother, vol.40, pp.1768-74, 1996.

A. Cheng, W. Yew, and E. Chan, Multiplex PCR Amplimer Conformation Analysis for Rapid Detection of gyrA Mutations in Fluoroquinolone-Resistant Mycobacterium tuberculosis Clinical Isolates, Antimicrobial Agents and Chemotherapy, vol.48, issue.2, pp.596-601, 2004.
DOI : 10.1128/AAC.48.2.596-601.2004

A. Aubry, N. Veziris, and E. Cambau, Novel Gyrase Mutations in Quinolone-Resistant and -Hypersusceptible Clinical Isolates of Mycobacterium tuberculosis: Functional Analysis of Mutant Enzymes, Antimicrobial Agents and Chemotherapy, vol.50, issue.1, pp.104-116, 2006.
DOI : 10.1128/AAC.50.1.104-112.2006

K. Guinn, M. Hickey, and S. Mathur, Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis, Molecular Microbiology, vol.66, issue.2, pp.359-70, 2004.
DOI : 10.1128/jb.178.5.1274-1282.1996

K. Brudey, M. Gutierrez, and V. Vincent, Mycobacterium africanum Genotyping Using Novel Spacer Oligonucleotides in the Direct Repeat Locus, Journal of Clinical Microbiology, vol.42, issue.11, pp.5053-5060, 2004.
DOI : 10.1128/JCM.42.11.5053-5057.2004

H. Takiff and O. Feo, Clinical value of whole-genome sequencing of Mycobacterium tuberculosis, The Lancet Infectious Diseases, vol.15, issue.9, pp.1077-90, 2015.
DOI : 10.1016/S1473-3099(15)00071-7

R. Lee and M. Behr, The implications of whole-genome sequencing in the control of tuberculosis. Therapeutic advances in infectious disease 2016, pp.47-62

A. Roetzer, R. Diel, and T. Kohl, Whole Genome Sequencing versus Traditional Genotyping for Investigation of a Mycobacterium tuberculosis Outbreak: A Longitudinal Molecular Epidemiological Study, PLoS Medicine, vol.101, issue.2, p.1001387, 2013.
DOI : 10.1371/journal.pmed.1001387.s006

J. Kamerbeek, L. Schouls, and A. Kolk, Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J Clin Microbiol, vol.35, pp.907-921, 1997.

R. Sorek, V. Kunin, and P. Hugenholtz, CRISPR ??? a widespread system that provides acquired resistance against phages in bacteria and archaea, Nature Reviews Microbiology, vol.7, issue.3, 2008.
DOI : 10.1038/nrmicro1793

A. Mihret, Y. Bekele, and A. Loxton, Diversity of Mycobacterium tuberculosis isolates from new pulmonary tuberculosis cases in Addis Ababa, Ethiopia, Tuberculosis research and treatment, vol.2012, p.892079, 2012.

N. Smith, T. Crawshaw, and J. Parry, Mycobacterium microti: More Diverse than Previously Thought, Journal of Clinical Microbiology, vol.47, issue.8, pp.2551-2560, 2009.
DOI : 10.1128/JCM.00638-09
URL : http://jcm.asm.org/content/47/8/2551.full.pdf

Y. Zhang, M. Coyne, and S. Will, Single-base mutational analysis of cancer and genetic diseases using membrane bound modified oligonucleotides, Nucleic Acids Research, vol.19, issue.14, pp.3929-3962, 1991.
DOI : 10.1093/nar/19.14.3929

C. Sola, E. Abadia, L. Hello, and S. , High-Throughput CRISPR Typing of Mycobacterium tuberculosis Complex and Salmonella enterica Serotype Typhimurium, Methods in molecular biology, vol.1311, pp.91-109, 2015.
DOI : 10.1007/978-1-4939-2687-9_6
URL : https://hal.archives-ouvertes.fr/pasteur-01159705

V. Moalic, B. Mercier, and C. Ferec, Technologie Luminex?????: principe, applications, et perspectives, Immuno-analyse & Biologie Sp??cialis??e, vol.19, issue.4, p.7, 2004.
DOI : 10.1016/S0923-2532(04)00057-2

T. Luo, C. Yang, and S. Gagneux, Combination of Single Nucleotide Polymorphism and Variable-Number Tandem Repeats for Genotyping a Homogenous Population of Mycobacterium tuberculosis Beijing Strains in China, Journal of Clinical Microbiology, vol.50, issue.3, pp.633-642, 2012.
DOI : 10.1128/JCM.05539-11

A. Asante-poku, M. Nyaho, and S. Borrell, Evaluation of Customised Lineage-Specific Sets of MIRU-VNTR Loci for Genotyping Mycobacterium tuberculosis Complex Isolates in Ghana, PLoS ONE, vol.3, issue.12, p.92675, 2014.
DOI : 10.1371/journal.pone.0092675.s001

C. Allix-beguec, C. Wahl, and M. Hanekom, Proposal of a Consensus Set of Hypervariable Mycobacterial Interspersed Repetitive-Unit-Variable-Number Tandem-Repeat Loci for Subtyping of Mycobacterium tuberculosis Beijing Isolates, Journal of Clinical Microbiology, vol.52, issue.1, pp.164-72, 2014.
DOI : 10.1128/JCM.02519-13
URL : https://hal.archives-ouvertes.fr/pasteur-01011025

L. Zhao, T. Xiao, and Q. Sun, Mutations in lysX as the new and reliable markers for tuberculosis Beijing and modern Beijing strains, Tuberculosis, vol.97, pp.33-40, 2016.
DOI : 10.1016/j.tube.2015.12.006

S. Chakravorty, B. Aladegbami, and A. Motiwala, Rifampin Resistance, Beijing-W Clade-Single Nucleotide Polymorphism Cluster Group 2 Phylogeny, and the Rv2629 191-C Allele in Mycobacterium tuberculosis Strains, Journal of Clinical Microbiology, vol.46, issue.8, pp.2555-60, 2008.
DOI : 10.1128/JCM.00666-08

W. Organization, The shorter MDR-TB regimen, 2016.

K. Chang, W. Yew, and Y. Zhang, Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses, Antimicrobial Agents and Chemotherapy, vol.55, issue.10, pp.4499-505, 2011.
DOI : 10.1128/AAC.00630-11

C. Pierre-audigier, C. Surcouf, and V. Cadet-daniel, Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis [Short communication], The International Journal of Tuberculosis and Lung Disease, vol.16, issue.2, pp.221-224, 2012.
DOI : 10.5588/ijtld.11.0266

Y. Zhang, C. Chang, K. Leung, and C. , ???ZS-MDR-TB??? versus ???ZR-MDR-TB???: improving treatment of MDR-TB by identifying pyrazinamide susceptibility, Emerging Microbes and Infections, vol.366, issue.7, p.5, 2012.
DOI : 10.1056/NEJMoa1112433
URL : http://www.nature.com/emi/journal/v1/n7/pdf/emi201218a.pdf

D. Andersson and D. Hughes, Microbiological effects of sublethal levels of antibiotics, Nature Reviews Microbiology, vol.172, issue.7, pp.465-78, 2014.
DOI : 10.1093/jac/17.4.409

Z. Baharoglu, E. Krin, and D. Mazel, RpoS Plays a Central Role in the SOS Induction by Sub-Lethal Aminoglycoside Concentrations in Vibrio cholerae, PLoS Genetics, vol.336, issue.4, p.1003421, 2013.
DOI : 10.1371/journal.pgen.1003421.t002

Z. Baharoglu and D. Mazel, Vibrio cholerae Triggers SOS and Mutagenesis in Response to a Wide Range of Antibiotics: a Route towards Multiresistance, Antimicrobial Agents and Chemotherapy, vol.55, issue.5, pp.2438-2479, 2011.
DOI : 10.1128/AAC.01549-10
URL : https://hal.archives-ouvertes.fr/pasteur-01423615

K. Chang, C. Leung, and W. Yew, Pyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant Tuberculosis, Antimicrobial Agents and Chemotherapy, vol.56, issue.11, pp.5465-75, 2012.
DOI : 10.1128/AAC.01300-12
URL : http://aac.asm.org/content/56/11/5465.full.pdf

M. Ibrahim, K. Andries, and N. Lounis, Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis, Antimicrobial Agents and Chemotherapy, vol.51, issue.3, pp.1011-1016, 2007.
DOI : 10.1128/AAC.00898-06
URL : http://aac.asm.org/content/51/3/1011.full.pdf

M. Bastos, H. Hussain, and K. Weyer, Treatment outcomes of patients with multidrugresistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first-and second-line drugs: an individual patient data meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of, America, vol.59, pp.1364-74, 2014.

U. Bidovec-stojkovi?, K. Seme, and M. ?olnir-dov?, Prospective Genotyping of Mycobacterium tuberculosis from Fresh Clinical Samples, PLoS ONE, vol.52, issue.5, p.10, 2014.
DOI : 10.1371/journal.pone.0109547.s002

A. Brown, J. Bryant, and K. Einer-jensen, Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples, Journal of Clinical Microbiology, vol.53, issue.7, pp.2230-2237, 2015.
DOI : 10.1128/JCM.00486-15
URL : http://jcm.asm.org/content/53/7/2230.full.pdf

C. Bouakaze, C. Keyser, and A. Gonzalez, Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Single Nucleotide Polymorphism Genotyping Assay Using iPLEX Gold Technology for Identification of Mycobacterium tuberculosis Complex Species and Lineages, Journal of Clinical Microbiology, vol.49, issue.9, pp.3292-3301, 2011.
DOI : 10.1128/JCM.00744-11

E. Khechine, A. Couderc, C. Flaudrops, and C. , Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Identification of Mycobacteria in Routine Clinical Practice, PLoS ONE, vol.4, issue.9, p.24720, 2011.
DOI : 10.1371/journal.pone.0024720.s001

C. Dye and B. Williams, Criteria for the control of drug-resistant tuberculosis, Proceedings of the National Academy of Sciences, vol.48, issue.30, pp.8180-8185, 2000.
DOI : 10.1073/pnas.95.7.3949

S. Belard, J. Remppis, and S. Bootsma, Tuberculosis Treatment Outcome and Drug Resistance in Lambar??n??, Gabon: A Prospective Cohort Study, The American Journal of Tropical Medicine and Hygiene, vol.95, issue.2, 2016.
DOI : 10.4269/ajtmh.15-0668

A. Pio and P. Chaulet, Tuberculosis handbook, Geneva: WHO, 1998.

S. Ramirez-busby and F. Valafar, Systematic Review of Mutations in Pyrazinamidase Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis Clinical Isolates, Antimicrobial Agents and Chemotherapy, vol.59, issue.9
DOI : 10.1128/AAC.00204-15

A. Sandgren, M. Strong, and P. Muthukrishnan, Tuberculosis Drug Resistance Mutation Database, PLoS Medicine, vol.40, issue.2, p.2, 2009.
DOI : 10.1371/journal.pmed.1000002.sd001
URL : https://doi.org/10.1371/journal.pmed.1000002

A. Alame-emane, P. Xu, and C. Pierre-audigier, Pyrazinamide resistance in <I>Mycobacterium tuberculosis</I> arises after rifampicin and fluoroquinolone resistance, The International Journal of Tuberculosis and Lung Disease, vol.19, issue.6, pp.679-84, 2015.
DOI : 10.5588/ijtld.14.0768

A. Pym, B. Saint-joanis, and S. Cole, Effect of katG Mutations on the Virulence of Mycobacterium tuberculosis and the Implication for Transmission in Humans, Infection and Immunity, vol.70, issue.9, pp.4955-60, 2002.
DOI : 10.1128/IAI.70.9.4955-4960.2002

M. Hazbon, M. Brimacombe, B. Del-valle, and M. , Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.50, issue.8, pp.2640-2649, 2006.
DOI : 10.1128/AAC.00112-06

S. Walusimbi, F. Bwanga, D. Costa, and A. , Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis, BMC Infectious Diseases, vol.9, issue.6, p.507, 2013.
DOI : 10.1186/1471-2334-9-67

L. Martin, J. Coronel, and D. Faulx, A Field Evaluation of the Hardy TB MODS Kit??? for the Rapid Phenotypic Diagnosis of Tuberculosis and Multi-Drug Resistant Tuberculosis, PLoS ONE, vol.18, issue.258, p.107258, 2014.
DOI : 10.1371/journal.pone.0107258.s005

L. Rigouts, N. Coeck, and M. Gumusboga, gene mutations predict poor treatment outcome in MDR-TB, Journal of Antimicrobial Chemotherapy, vol.71, issue.2, pp.314-337, 2016.
DOI : 10.1093/jac/dkv360
URL : https://academic.oup.com/jac/article-pdf/71/2/314/6993252/dkv360.pdf

F. Koro-koro, Y. Simo, and F. Piam, Population Dynamics of Tuberculous Bacilli in Cameroon as Assessed by Spoligotyping, Journal of Clinical Microbiology, vol.51, issue.1, p.4, 2013.
DOI : 10.1128/JCM.01196-12
URL : https://hal.archives-ouvertes.fr/pasteur-00835858

L. Fenner, S. Gagneux, and G. Kabuya, Mycobacterium tuberculosis genetic diversity and drug resistance confering mutations in the Democratic Republic of Congo, East African Medical Journal, vol.88, p.7, 2011.